kotak-logo

Vedanta Stock Jumps Before Key NCLAT Hearing On JAL Dispute

vedanta-shares-rise-nclat-hearing-jal-case

You can set Kotak Neo as a preferred source to receive regular market updates.

Add as preferred source on Google

Vedanta shares climbed over 4% before the April 10 NCLAT hearing, where it challenges Adani’s ₹14,535 crore JAL bid. Will the outcome shift the balance? Read more.

Vedanta's stock surged by 4%, reaching a high of ₹718.80 on the Bombay Stock Exchange (BSE) due to investor positioning before an important court hearing in the insolvency proceedings of Jaiprakash Associates. At 1:13 pm, Vedanta’s share price stood at ₹711 on the BSE, indicating consistent demand.

This move comes a day after the Supreme Court of India allowed the resolution process for Jaiprakash Associates Ltd (JAL) to continue without a stay, while putting guardrails in place. The court asked both Vedanta Limited and Adani Enterprises to take their arguments to the appellate tribunal, which will hear the matter on 10 April.

The immediate trigger is the upcoming hearing at the National Company Law Appellate Tribunal. This is where Vedanta is contesting the approval of Adani’s ₹14,535 crore resolution plan.

Vedanta’s stance is straightforward. It says its own bid, pegged at ₹17,926 crore, offers better value to lenders. The company has also claimed that creditors could recover roughly ₹3,400 crore more under its proposal.

But the lenders had already voted in favour of Adani’s plan last year. Their decision leaned on quicker payouts and a sizeable upfront cash component, factors that often carry weight in stressed asset resolutions.

Monday’s Supreme Court order did not change that outcome, but it did slow things down slightly. The monitoring committee running JAL has been told not to take any major policy calls without the tribunal’s approval.

That pause has given the market a window to reassess possibilities, and that is showing up in Vedanta’s stock movement.

This case of corporate insolvency isn’t an ordinary fight over money. Jaiprakash Associates is dealing with multiple players, big debts, and other conflicts, making it quite complicated.

From the creditors’ point of view, there's more to the bidding process than simply looking at which bid seems worth more in terms of total value. Adani is offering the funds within two years, while Vedanta has a longer payout of five years.

The appellate tribunal’s decision could influence how such trade-offs are judged in future cases under India’s insolvency framework. It will also signal how much weight is given to upfront cash versus total value.

The Supreme Court has already nudged the process towards a quicker conclusion by asking the tribunal to hear the matter on priority.

Also Read - Gold And Silver Prices Ease On COMEX As Geopolitical Tensions Keep Traders Cautious

Beyond the legal angle, there is also some support coming from the street. JPMorgan Chase has upgraded Vedanta to “Overweight” and raised its price target.

The brokerage is betting on stronger aluminium prices and supportive currency trends. It also noted that current valuations look reasonable, especially if commodity tailwinds continue.

That said, the near-term direction of the stock may still hinge on 10 April. A favourable turn at the tribunal could reopen the conversation around bids, while an unfavourable outcome may settle the matter.

For now, the market appears to be pricing in that uncertainty, one hearing at a time.

Sources

Mint

ET Now

This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262.

About the Author
Kotak News Desk
Kotak News Desk

Kotak News Desk brings you latest updates, expert insights, and market-ready ideas - helping you stay informed and invest smarter.

Connect on: Linkedin

...Read More
Did you enjoy this article?

0 people liked this article.